AI skills could mean higher pay, PwC research finds May 21, 2024 PwC has found that jobs which involve AI could pay higher and are experiencing a booming productivity growth rate.
New Semiconductor Institute welcomed by UK chip sector as part of £1bn strategy May 20, 2024 The new semiconductor institute is tasked with promoting the sector to investors and attracting foreign investment in British research.
British terrorism reinsurer warns extremists are ‘actively experimenting’ with AI to carry out attacks May 20, 2024 Terrorism sympathisers have recently begun using AI to create optical illusions as one method of distributing propaganda, the report said.
Nexxen: Share price rises on record first quarter revenue and bumper buyback May 20, 2024 London-listed company Nexxen also said it has launched a $50m (£39.4m) share buy back programme on Monday.
Kainos: NHS supplier reports 14th year of growth as it ramps up use of AI May 20, 2024 Kainos, a key NHS supplier, warned of weak demand from commercial clients in April and this was reflected in bookings.
UK’s AI Safety Institute set to open in San Francisco May 20, 2024 The British government is hoping the new office will allow the UK to tap into Silicon Valley's tech talent and strengthen ties with the US.
Nvidia eyes strong first quarter results as analysts remain bullish May 19, 2024 This AI hype has enabled Nvidia to annihilate consensus sales and profit forecasts in all four quarters of the financial year 2024.
Pragmatic: ‘More to be done’ says boss of British chipmaker May 19, 2024 The chief of Pragmatic has said good progress has been made but there is "more to be done" to support Britain’s semiconductor industry.
Euan Blair shrugs off Multiverse troubles to become one of Britain’s richest people May 17, 2024 Tony Blair’s son Euan has appeared on a list of the richest Brits for the first time on the back of a hefty stake in his educational tech ‘unicorn’ Multiverse.
GSK raises £1.25bn as it offloads final stake in Haleon May 17, 2024 The move separates the companies after a carve-up twoo years ago that saw GSK spin off and float its consumer arm as Haleon, amid fears the division was weighing on the growth of its dedicated healthcare business.